Affiliations
Aram Lyu, Zenghua Fan, Matthew Clark, Averey Lea, Diamond Luong, Ali Setayesh, Alec Starzinski, Rachel Wolters, Marcel Arias-Badia, Kate Allaire, Kai Wu, Vibha Gurunathan, Laura Valderrábano, Xiao X Wei, Richard A Miller, Eliezer M Van Allen, Lawrence Fong
DOI: 10.1038/s41586-024-08290-3
Abstract
Patients with advanced metastatic castration-resistant prostate cancer (mCRPC) are refractory to immune checkpoint inhibitors (ICIs)
Keywords
mCRPC，CD3，ICIs
関連製品
| カタログ番号 | 製品名 | 説明 | ターゲット |
|---|---|---|---|
| HY057507 | CD3 | T3E, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, CD3E, T-cell surface glycoprotein CD3 epsilon chain |
+86-027-65523339
中国武漢市深敦寺路666号C棟、武漢、430206
中文
English
한국어
日本語
Español
Français
Русский